Mr. Speaker, together we have made huge progress in reducing drug costs for Canadians. By working together on bulk purchasing, $3.5 billion less is now spent by Canadians by reducing those costs. We need to and must do much more. That is why we are continuing to work, not only with the party opposite, the New Democrats, but also with all parties, with a strategy on rare diseases and with the introduction of legislation on pharmacare. Together, we can make sure that Canadians are not faced with the impossible choice of essentials or the medicine they need.
In the House of Commons on October 5th, 2023. See this statement in context.